So far, there are several models for predicting HCC prognosis, using different gene signatures such as HOXD9, SPP1, SPINK1, TXNRD1 and MAGEB6, and the satisfying performances of those models suggested that these genes could serve as possible drug targets (8, 9). Here, TXNRD1 is linked to hepatocellular carcinoma.